Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -37.38% is 44% above its 5-year average of -66.19%, near the high end of its 5-year range (-254.19%–-13.90%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.84% above its 12-month average of -38.08%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -37.38%.
RETURN ON EQUITY (ROE)
-37.38%
RETURN ON EQUITY (ROE) AVG TTM
-38.08%
RETURN ON EQUITY (ROE) AVG 3Y
-40.57%
RETURN ON EQUITY (ROE) AVG 5Y
-66.19%
RETURN ON EQUITY (ROE) AVG 10Y
-54.04%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+1.84%
CURRENT VS 3Y AVG
+7.86%
CURRENT VS 5Y AVG
+43.52%
CURRENT VS 10Y AVG
+30.83%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 621 covered companies
CURRENT VS SECTOR MEDIAN
+7.01%
vs the sector median at left
Ardelyx, Inc.
Market Cap
$815.07M
Return on Equity (ROE)
-37.38%
TTM Avg
-38.08%
3Y Avg
-40.57%
5Y Avg
-66.19%
Market Cap
$819.99M
Return on Equity (ROE)
N/A
TTM Avg
-5137.85%
3Y Avg
-2593.82%
5Y Avg
-1731.57%
Market Cap
$804.44M
Return on Equity (ROE)
12.32%
TTM Avg
19.75%
3Y Avg
23.44%
5Y Avg
27.16%
Market Cap
$823.83M
Return on Equity (ROE)
-34.83%
TTM Avg
-64.71%
3Y Avg
-59.77%
5Y Avg
-96.53%
Market Cap
$802.16M
Return on Equity (ROE)
-13.30%
TTM Avg
11.91%
3Y Avg
154.09%
5Y Avg
54.89%
Market Cap
$796.49M
Return on Equity (ROE)
-16.56%
TTM Avg
0.55%
3Y Avg
-10.56%
5Y Avg
-13.37%
Market Cap
$838.75M
Return on Equity (ROE)
-97.08%
TTM Avg
-96.94%
3Y Avg
-22.72%
5Y Avg
-22.72%
Market Cap
$792.28M
Return on Equity (ROE)
-31.97%
TTM Avg
-50.13%
3Y Avg
-87.97%
5Y Avg
-79.93%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $815.07M | -37.38% | -38.08% | -40.57% | -66.19% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $819.99M | N/A | -5137.85% | -2593.82% | -1731.57% |
| InMode Ltd. (INMD)vs › | $804.44M | 12.32% | 19.75% | 23.44% | 27.16% |
| Apnimed, Inc. (APMD)vs › | $800.45M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $823.83M | -34.83% | -64.71% | -59.77% | -96.53% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $802.16M | -13.30% | 11.91% | 154.09% | 54.89% |
| AdaptHealth Corp. (AHCO)vs › | $796.49M | -16.56% | 0.55% | -10.56% | -13.37% |
| Alumis Inc. (ALMS)vs › | $838.75M | -97.08% | -96.94% | -22.72% | -22.72% |
| Geron Corporation (GERN)vs › | $792.28M | -31.97% | -50.13% | -87.97% | -79.93% |
| Beta Bionics, Inc. (BBNX)vs › | $846.26M | -28.46% | -48.75% | -33.66% | -33.66% |
ROE
-37.4%
ROA
-9.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -37.38% |
| 2026-03-31 | -39.07% |
| 2025-12-31 | -36.90% |
| 2025-09-30 | -36.65% |
| 2025-06-30 | -40.41% |
| 2025-03-31 | -36.91% |
| 2024-12-31 | -22.58% |
| 2024-09-30 | -45.85% |
| 2024-06-30 | -44.32% |
| 2024-03-31 | -43.62% |
| 2023-12-31 | -39.60% |
| 2023-09-30 | -13.90% |
| 2023-06-30 | -45.54% |
| 2023-03-31 | -52.55% |
| 2022-12-31 | -68.35% |
| 2022-09-30 | -170.71% |
| 2022-06-30 | -254.19% |
| 2022-03-31 | -238.48% |
| 2021-12-31 | -191.44% |
| 2021-09-30 | -185.19% |
| 2021-06-30 | -106.60% |
| 2021-03-31 | -80.34% |
| 2020-12-31 | -74.79% |
| 2020-09-30 | -64.89% |
| 2020-06-30 | -61.95% |
| 2020-03-31 | -54.35% |
| 2019-12-31 | -50.86% |
| 2019-09-30 | -209.55% |
| 2019-06-30 | -150.98% |
| 2019-03-31 | -109.34% |
| 2018-12-31 | -78.83% |
| 2018-09-30 | -37.70% |
| 2018-06-30 | -30.55% |
| 2018-03-31 | -41.36% |
| 2017-12-31 | -46.18% |
| 2017-09-30 | -83.49% |
| 2017-06-30 | -78.66% |
| 2017-03-31 | -69.73% |
| 2016-12-31 | -58.19% |
| 2016-09-30 | -44.02% |
| 2016-06-30 | -62.02% |
| 2016-03-31 | -29.56% |
| 2015-12-31 | -27.20% |
| 2015-09-30 | -13.26% |
| 2015-06-30 | 1.13% |
| 2015-03-31 | -6.28% |
| 2014-12-31 | -5.30% |
| 2014-09-30 | -5.55% |
| 2014-06-30 | -7.19% |
